Why the study?
What are the outcomes and prognostic factors for patients with synovial sarcoma treated at a single institution?
Population
250 patients with synovial sarcoma who underwent surgery at the Rizzoli Institute between 1976 and 2006.
Design
Cohort
Follow-up
median 5.5 years (range, 1-30 years)
Authors
Loading...
Stage strongly predicts survival in synovial sarcoma; supports surgery for localized disease but leaves open systemic options for metastatic cases.
What are the outcomes and prognostic factors for patients with synovial sarcoma treated at a single institution?
In patients with localized synovial sarcoma, a good rate of cure can be achieved with surgery, with age, size, histology, and radiotherapy influencing prognosis.
Palmerini et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: